Durham, North Carolina, United States Pappas Capital is the famous VC, which was founded in 1994. The main department of described VC is located in the Durham. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Pappas Capital, startups are often financed by Fonds de solidaritu00e9 FTQ, Pappas Ventures, Go Capital. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Tekla Capital Management, RiverVest. In the next rounds fund is usually obtained by Venrock Healthcare Partners, Tekla Capital Management, RTW Investments LLC.
Among the most popular fund investment industries, there are Genetics, Health Care. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CuraSen Therapeutics, 4D Molecular Therapeutics, Amplyx Pharmaceuticals.
Comparing to the other companies, this Pappas Capital performs on 11 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2019. The top activity for fund was in 2018. The common things for fund are deals in the range of 50 - 100 millions dollars.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Asatsu DK | Hokkaido Prefecture, Japan, Sapporo |
| Bank of Kochi | Japan, Kochi, Kochi Prefecture |
| Beilun ZhongGang ZhuangShi | China, Ningbo, Zhejiang |
| BonVenture | Bayern, Germany, Munich |
| Changan Assets | China, Shanghai |
| Charitable Leadership Foundation | Clifton Park, New York, United States |
| Clearly Social Angels | England, London, United Kingdom |
| Dera Game | Japan, Tokyo |
| FourthGreen Capital | Incline Village, Nevada, United States |
| Huaou Equity Investment | China, Hangzhou, Zhejiang |
| KBL Healthcare Ventures | New York, New York, United States |
| Lead Wealth Capital | China, Shanghai |
| Orient Corporation | Chiyoda, Japan |
| Shantou Dongfeng Venture Capital | China, Guangdong, Shantou |
| Sylvain & CO | - |
| Taleria Ventures | - |
| TLC Capital | Atlanta, Georgia, United States |
| Walvax Biotechnology | China, Kunming, Yunnan |
| Werth Family Investment Associates | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Enlaza Therapeutics | $100M | 30 Apr 2024 | La Jolla, California, United States | ||
Horizon Quantum Computing | $18M | 31 Mar 2023 | Singapore, Central, Singapore | ||
VFlow Tech | $10M | 07 Feb 2023 | Singapore, Central, Singapore | ||
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
NuProbe | $50M | 02 Jun 2022 | Boston, Massachusetts, United States | ||
Us2.ai | $15M | 14 Apr 2022 | Singapore, Central Region, Singapore | ||
Plexium | $102M | 23 Feb 2022 | San Diego, California, United States | ||
AvengeBio | $45M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
Reneo Pharmaceuticals | $95M | 09 Dec 2020 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Enlaza Therapeutics | $100M | 30 Apr 2024 | La Jolla, California, United States | ||
Horizon Quantum Computing | $18M | 31 Mar 2023 | Singapore, Central, Singapore | ||
VFlow Tech | $10M | 07 Feb 2023 | Singapore, Central, Singapore | ||
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
NuProbe | $50M | 02 Jun 2022 | Boston, Massachusetts, United States | ||
Us2.ai | $15M | 14 Apr 2022 | Singapore, Central Region, Singapore | ||
Plexium | $102M | 23 Feb 2022 | San Diego, California, United States | ||
AvengeBio | $45M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
Reneo Pharmaceuticals | $95M | 09 Dec 2020 | San Diego, California, United States |
